Why Catalyst Pharmaceuticals Shares Are Popping Off

Catalyst Pharmaceuticals Inc. CPRX shares are trading higher by 6.40% to $16.12 Tuesday after it was announced the company will join the S&P SmallCap 600.

Catalyst Pharmaceuticals will replace Mantech International Corp. MANT in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, September 15.

The Carlyle Group Inc. CG is acquiring ManTech International in a transaction expected to be completed soon pending final conditions.

See Also: Here's How Much You'd Have Right Now If You Invested $1,000 In Apple Shares When Steve Jobs Resigned As CEO In 2011

According to data from Benzinga Pro, Catalyst Pharmaceuticals has a 52-week high of $17.22 and a 52-week low of $4.81.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Small CapMoversTrading Ideaswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!